Detalles de la búsqueda
1.
Treatment adherence and support for people who inject drugs taking direct-acting antiviral therapy for hepatitis C infection.
J Viral Hepat
; 26(11): 1301-1310, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31299127
2.
Preparing for a syndemic: incorporating opioid overdose management into routine care for people who inject drugs initiating hepatitis C treatment.
Intern Med J
; 50(3): 382-383, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32141211
3.
Hepatitis C (HCV) Reinfection and Risk Factors among Clients of a Low-Threshold Primary Healthcare Service for People Who Inject Drugs in Sydney, Australia.
Viruses
; 16(6)2024 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38932249
4.
Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot Study.
Int J Drug Policy
; 114: 103982, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36863287
5.
The Overdose Response with Take Home Naloxone (ORTHN) project: Evaluation of health worker training, attitudes and perceptions.
Drug Alcohol Rev
; 41(5): 1085-1094, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35442514
6.
Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot Study.
Viruses
; 14(11)2022 11 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36366561
7.
Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO-C): An open-label, single-arm, phase 4, multicentre trial.
Health Sci Rep
; 3(2): e151, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32270056
8.
Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives.
Drug Alcohol Rev
; 39(1): 55-65, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31774221
9.
Feasibility and acceptability of adherence support for direct acting antiviral therapy for hepatitis C in a low-threshold primary health-care opioid agonist treatment program.
Drug Alcohol Rev
; 38(2): 185-189, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30761640
10.
Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting.
Int J Drug Policy
; 47: 209-215, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28587943
Resultados
1 -
10
de 10
1
Próxima >
>>